冠状动脉微血管功能障碍的持续损伤在皮肤冠状动脉干预后在一个冰泳冠军的冰上游泳冠军
Gueladio Kone1, Matthieu Godin1, Alexandre Fuzeau1
1Department of Cardiology, Clinique Saint-Hilaire, Rouen, France.
Journal of medical cases
|October 1, 2025
概括
冠状动脉微血管功能障碍 (CMD) 可以导致冠状动脉干预后持续性心痛. 血管造影衍生微循环阻力 (AMR) 在PCI后患者中有效识别了CMD,支持其诊断用途.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心血管成像 - 心血管成像
背景情况:
- 冠状动脉微血管功能障碍 (CMD) 是皮肤冠状动脉干预 (PCI) 后心痛的一个重要原因,特别是在没有阻塞性心上冠状动脉疾病的患者中.
- 在PCI后持续的症状需要彻底调查除了上心狭窄之外的潜在原因.
研究的目的:
- 报告PCI后持续性呼吸障碍病例.
- 为了说明血管学衍生微循环阻力 (AMR) 在识别CMD的诊断效用.
- 突出AMR在PCI后心脏病发作中的作用.
主要方法:
- 一个案例报告,一名58岁的精英运动员在成功进行PCI后,因为左前下降动脉损伤而经历了持续性呼吸障碍.
- 随访冠状动脉扫描与光学连贯性断层扫描 (OCT) 以评估支架透度和位置.
- 评估心脏功能和微循环,使用血管学衍生的微循环阻力 (AMR) 和心脏磁共振成像 (CMR).
主要成果:
- 随访血管造影和OCT证实没有静脉静脉复缩和良好的静脉静脉部署.
- 无论是AMR还是CMR成像,都确定了冠状动脉微血管功能障碍 (CMD) 是患者持续症状的原因.
- 该案例证明了使用AMR用于PCI后的CMD诊断的可行性.
结论:
- 冠状动脉微血管功能障碍 (CMD) 即使在成功进行PCI后,也可以表现为持续性心痛或呼吸障碍.
- 血管造影衍生微循环阻力 (AMR) 是一种有价值和可行的工具,用于诊断PCI后的CMD.
- 在冠状动脉干预后持续症状的患者的诊断算法中应考虑AMR.
相关概念视频
01:27Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
01:28Acute Coronary Syndrome IV: Interprofessional Care
220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
01:27Peripheral Artery Disease III: Interprofessional Care
245
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
245
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
363
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
363
01:30Peripheral Artery Disease I: Introduction
314
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
314
01:26Coronary Artery Disease II: Pathophysiology
374
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
374